Literature DB >> 15471698

Mass drug administration to eliminate lymphatic filariasis in India.

Kapa D Ramaiah1, Pradeep K Das.   

Abstract

Mass drug administration (MDA) to eliminate lymphatic filariasis is already in place in 32 out of 83 endemic countries. Expansion of the MDA programme to other countries and within large countries such as India is necessary to achieve the goal of lymphatic filariasis elimination. However, expansion and sustenance of the global campaign to eliminate lymphatic filariasis requires commitment and allocation of funds by governments and donor agencies. This could be achieved, at least to some extent, by highlighting the benefits of the programme in relation to costs. On the basis of various studies in south India, this article assesses the costs, effectiveness and economic and social benefits of the MDA programmes aimed at eliminating lymphatic filariasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15471698     DOI: 10.1016/j.pt.2004.08.010

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  12 in total

1.  Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs.

Authors:  Dominique Kyelem; Gautam Biswas; Moses J Bockarie; Mark H Bradley; Maged El-Setouhy; Peter U Fischer; Ralph H Henderson; James W Kazura; Patrick J Lammie; Sammy M Njenga; Eric A Ottesen; Kapa D Ramaiah; Frank O Richards; Gary J Weil; Steven A Williams
Journal:  Am J Trop Med Hyg       Date:  2008-10       Impact factor: 2.345

Review 2.  Lymphatic Filariasis in India : Problems, Challenges and New Initiatives.

Authors:  V K Agrawal; V K Sashindran
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.

Authors:  K D Ramaiah; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

4.  An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of gujarat.

Authors:  Pradeep Kumar; Pb Prajapati; Deepak Saxena; Abhay B Kavishwar; George Kurian
Journal:  Indian J Community Med       Date:  2008-01

Review 5.  Controlling lymphatic filariasis and soil-transmitted helminthiasis together in South Asia: opportunities and challenges.

Authors:  E A Padmasiri; A Montresor; G Biswas; N R de Silva
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-03-20       Impact factor: 2.184

6.  Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

Authors:  Wilma A Stolk; Quirine A ten Bosch; Sake J de Vlas; Peter U Fischer; Gary J Weil; Ann S Goldman
Journal:  PLoS Negl Trop Dis       Date:  2013-01-03

7.  Global socioeconomic impact of cystic echinococcosis.

Authors:  Christine M Budke; Peter Deplazes; Paul R Torgerson
Journal:  Emerg Infect Dis       Date:  2006-02       Impact factor: 6.883

8.  The global programme to eliminate lymphatic filariasis: health impact after 8 years.

Authors:  Eric A Ottesen; Pamela J Hooper; Mark Bradley; Gautam Biswas
Journal:  PLoS Negl Trop Dis       Date:  2008-10-08

9.  Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes.

Authors:  Edwin Michael; Mwele N Malecela; Mihail Zervos; James W Kazura
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

10.  Mass drug administration for elimination of lymphatic filariasis: Recent experiences from a district of West Bengal, India.

Authors:  Santanu Ghosh; Amrita Samanta; Seshadri Kole
Journal:  Trop Parasitol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.